Physician profile
James Donecker
NPI 1720341589
$771.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $625 · 2021: $146.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $144.05 | 2020-2021 | |
| Glaxosmithkline, LLC. | $111.65 | 2020-2021 | |
| Radius Health, INC. | $99.47 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $86.09 | 2020 | |
| Abbvie INC. | $72.90 | 2020-2021 | |
| Allergan, INC. | $56.08 | 2020 | |
| Merck Sharp & Dohme LLC | $46.82 | 2020-2021 | |
| Alfasigma USA, INC. | $28.36 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.89 | 2020-2021 | |
| Adamas Pharmaceuticals, INC. | $23.92 | 2020 | |
| Lilly USA, LLC | $22.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.63 | 2020 | |
| Ironwood Pharmaceuticals, INC | $18.60 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.75 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Donecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.